Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Suppression of intestinal polyp development by low-fat and high-fiber diet in Apc(delta716) knockout mice.

Hioki K, Shivapurkar N, Oshima H, Alabaster O, Oshima M, Taketo MM.

Carcinogenesis. 1997 Oct;18(10):1863-5.

PMID:
9363991
2.

Inhibition by wheat bran cereals of the development of aberrant crypt foci and colon tumours.

Alabaster O, Tang Z, Shivapurkar N.

Food Chem Toxicol. 1997 May;35(5):517-22.

PMID:
9216751
3.

Absence of p53 gene mutations in rat colon carcinomas induced through the synergistic interaction between methylazoxymethanol and X-irradiation.

Shivapurkar N, Nikula KJ, Tanaka T, Tang ZC, Alabaster O.

Cancer Lett. 1997 Feb 26;113(1-2):9-16.

PMID:
9065795
4.

Microsatellite instability in aberrant crypt foci from human colons.

Heinen CD, Shivapurkar N, Tang Z, Groden J, Alabaster O.

Cancer Res. 1996 Dec 1;56(23):5339-41.

5.

Fibre and colorectal cancer.

Alabaster O, Shivapurkar N.

Lancet. 1996 Oct 5;348(9032):957-8; author reply 959. No abstract available.

PMID:
8843823
6.

A rapid dual organ rat carcinogenesis bioassay for evaluating the chemoprevention of breast and colon cancer.

Shivapurkar N, Tang ZC, Frost A, Alabaster O.

Cancer Lett. 1996 Feb 27;100(1-2):169-79.

PMID:
8620438
7.

Dietary fiber and the chemopreventive modelation of colon carcinogenesis.

Alabaster O, Tang Z, Shivapurkar N.

Mutat Res. 1996 Feb 19;350(1):185-97.

PMID:
8657180
8.

The effect of dietary fat on the promotion of mammary and colon cancer in a dual-organ rat carcinogenesis model.

Tang ZC, Shivapurkar N, Frost A, Alabaster O.

Nutr Cancer. 1996;25(2):151-9.

PMID:
8710684
9.

Absence of p53 gene mutations in rat colon carcinomas induced by azoxymethane.

Shivapurkar N, Belinsky SA, Wolf DC, Tang Z, Alabaster O.

Cancer Lett. 1995 Sep 4;96(1):63-70.

PMID:
7553609
10.
11.
12.

Sequential analysis of K-ras mutations in aberrant crypt foci and colonic tumors induced by azoxymethane in Fischer-344 rats on high-risk diet.

Shivapurkar N, Tang Z, Ferreira A, Nasim S, Garett C, Alabaster O.

Carcinogenesis. 1994 Apr;15(4):775-8.

PMID:
8149495
13.

Potential synergism between wheat bran and psyllium: enhanced inhibition of colon cancer.

Alabaster O, Tang ZC, Frost A, Shivapurkar N.

Cancer Lett. 1993 Nov 30;75(1):53-8.

PMID:
8287381
14.

Fecal bile acid excretion and composition in response to changes in dietary wheat bran, fat and calcium in the rat.

Borum ML, Shehan KL, Fromm H, Jahangeer S, Floor MK, Alabaster O.

Lipids. 1992 Dec;27(12):999-1004.

PMID:
1336804
15.

The effect of high-risk and low-risk diets on aberrant crypt and colonic tumor formation in Fischer-344 rats.

Shivapurkar N, Tang ZC, Alabaster O.

Carcinogenesis. 1992 May;13(5):887-90.

PMID:
1316816
16.

Magnesium and calcium absorption in Fischer-344 rats influenced by changes in dietary fibre (wheat bran), fat and calcium.

Watkins DW, Jahangeer S, Floor MK, Alabaster O.

Magnes Res. 1992 Mar;5(1):15-21.

PMID:
1317206
17.

Serum gastrin increases with increasing dietary calcium but not with increasing dietary fat or fiber in Fischer-344 rats.

Floor MK, Jahangeer S, D'Ambrosio C, Alabaster O.

J Nutr. 1991 Jun;121(6):863-8.

PMID:
1851825
18.

Influence of microenvironmental pH on adriamycin resistance.

Alabaster O, Woods T, Ortiz-Sanchez V, Jahangeer S.

Cancer Res. 1989 Oct 15;49(20):5638-43.

19.
20.

pH dependence of mitomycin C-induced cross-linking activity in EMT6 tumor cells.

Kennedy KA, McGurl JD, Leondaridis L, Alabaster O.

Cancer Res. 1985 Aug;45(8):3541-7.

21.

A randomized trial to evaluate the immunorestorative properties of synthetic thymosin-alpha 1 in patients with lung cancer.

Schulof RS, Lloyd MJ, Cleary PA, Palaszynski SR, Mai DA, Cox JW Jr, Alabaster O, Goldstein AL.

J Biol Response Mod. 1985 Apr;4(2):147-58.

PMID:
3998766
22.

T-cell abnormalities after mediastinal irradiation for lung cancer. The in vitro influence of synthetic thymosin alpha-1.

Schulof RS, Chorba TL, Cleary PA, Palaszynski SR, Alabaster O, Goldstein AL.

Cancer. 1985 Mar 1;55(5):974-83.

PMID:
3155644
23.

Phenotypic and ultrastructural characterization of a medullary thymocyte acute lymphoblastic leukemia with cellular procoagulant activity.

Chorba TL, Orenstein JM, Ney AB, Schwartz BS, Alabaster O, Kessler CM, Cohen P, Schulof RS.

Cancer. 1985 Feb 1;55(3):675-81.

PMID:
3880664
24.

Inverse correlation between age related abnormalities of T-cell immunity and circulating thymosin alpha 1 levels in haemophilia A.

Kessler CM, Schulof RS, Alabaster O, Goldstein AL, Naylor PH, Phillips TM, Luban NL, Kelleher JF, Reaman GH.

Br J Haematol. 1984 Oct;58(2):325-36.

PMID:
6236839
25.

Tumor cell heterogeneity: its determination by flow cytometric analysis of intracellular pH.

Alabaster O, Carr KC, Leondaridis L.

Methods Achiev Exp Pathol. 1984;11:96-110. No abstract available.

PMID:
6700438
26.

Synthesis of kappa light chains by cell lines containing an 8;22 chromosomal translocation derived from a male homosexual with Burkitt's lymphoma.

Magrath I, Erikson J, Whang-Peng J, Sieverts H, Armstrong G, Benjamin D, Triche T, Alabaster O, Croce CM.

Science. 1983 Dec 9;222(4628):1094-8.

PMID:
6316501
27.

Metabolic modification by insulin enhances methotrexate cytotoxicity in MCF-7 human breast cancer cells.

Alabaster O, Vonderhaar BK, Shafie SM.

Eur J Cancer Clin Oncol. 1981 Nov;17(11):1223-8. No abstract available.

PMID:
7037424
28.

Induction of complement receptors in human cell lines derived from undifferentiated lymphomas.

Jaffe ES, Smith SA, Magrath IT, Freeman CB, Alabaster O, Sussman EH.

Lab Invest. 1981 Sep;45(3):295-301.

PMID:
7278135
29.

Collagen heterogeneity in normal human bone marrow.

Bentley SA, Alabaster O, Foidart JM.

Br J Haematol. 1981 Jun;48(2):287-91.

PMID:
7016167
30.

Phagocytic properties of bone marrow fibroblasts.

Bentley SA, Tralka TS, Alabaster O.

Exp Hematol. 1981 Apr;9(4):313-8.

PMID:
7238652
31.

Analysis of NZB hyperdiploid spleen cells.

Raveche ES, Alabaster O, Tjio JH, Taurog J, Steinberg AD.

J Immunol. 1981 Jan;126(1):154-60.

PMID:
7451964
32.

Analysis of the proliferation kinetics of Burkitt's lymphoma cells.

Woo KB, Funkhouser WK, Sullivan C, Alabaster O.

Cell Tissue Kinet. 1980 Nov;13(6):591-604.

PMID:
7417976
33.

Electrolytic degradation of DNA fluorochromes during flow cytometric measurement of electronic cell volume.

Alabaster O, Glaubiger DL, Hamilton VT, Bentley SA, Shackney SE, Skramstad KS, Chen RF.

J Histochem Cytochem. 1980 Apr;28(4):330-4.

PMID:
6445379
34.

Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. I. Physical, cytogenetic, and growth characteristics.

Magrath IT, Pizzo PA, Whang-Peng J, Douglass EC, Alabaster O, Gerber P, Freeman CB, Novikovs L.

J Natl Cancer Inst. 1980 Mar;64(3):465-76.

PMID:
6243721
35.

Quantitative cytology: new dimensions in automation and diagnosis.

Alabaster O, Bentley SA, Herman CJ.

Pathol Annu. 1979;14 Pt 2:1-21. No abstract available.

PMID:
398024
36.

Effects of cyclophosphamide on the mithramycin-DNA fluorescence of human lymphoma cells: a possible result of guanine alkylation.

Alabaster O, Magrath IT, Habbersett MC, Herman CJ.

J Histochem Cytochem. 1979 Jan;27(1):500-4. No abstract available.

PMID:
155711
37.
38.
39.

Measurement of cellular DNA mass by flow microfluorometry with use of a biological internal standard.

Tannenbaum E, Cassidy M, Alabaster O, Herman C.

J Histochem Cytochem. 1978 Feb;26(2):145-8.

PMID:
624835

Supplemental Content

Loading ...
Support Center